Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: randomized, double-blind, placebo-controlled clinical trial. Preliminary report.

Conclusions4-aminopyridine proved to be an effective treatment on cognitive aspects in patients with relapsing-remitting multiple sclerosis. Drug doses were shown to be safe with mild to moderate adverse events. (ClinicalTrials.gov number, NCT02280096).
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research